Medical costs in community subjects with irritable bowel syndrome

References 

1. Schieber GJ, Poullier J-P, Greenwald LM. U.S. health expenditure performance: an international comparison and data update. Health Care Financing Rev. 1992;13:1–15
2. Burner ST, Waldo DR, McKusick DR. National health expenditures projections through 2030. Health Care Financing Rev. 1992;14:1–29
3. Rublee DA, Schneider M. International health spending: comparisons with the OECD. Health Affairs. 1991;10:187–198
4. Congressional Budget Office . Trends in health care spending: an update. Washington, DC: U.S. Government Printing Office; June 1993;
5. Jacobs P. The economics of health and medical care. 3rd ed. Rockville, MD: Aspen Publishers; 1991;
6. Schramm CJ. Health care and its costs. New York: Norton; 1987;
7. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology. 1990;99:409–415
   • Abstract
   • Full-Text PDF (782 KB)
8. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991;101:927–934
   • Abstract
   • Full-Text PDF (794 KB)
9. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ. 1992;304:87–90
   • MEDLINE
   • CrossRef
10. Heaton KW, O'Donnell LJD, Braddon FEM, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology. 1992;102:1962–1967
    • Abstract
    • Full-Text PDF (563 KB)
11. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional GI disorders: prevalence, sociodemography and health impact. Dig Dis Sci. 1993;38:1569–1580
    • MEDLINE
    • CrossRef
12. Switz DM. What the gastroenterologist does all day. Gastroenterology. 1976;70:1048–1050
    • Abstract
13. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987;92:1282–1284
    • MEDLINE
14. Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a five-year prospective study. Lancet. 1987;1:963–965
    • MEDLINE
15. Campion ME, Naessens JM, Leibson CL, Shaller D, Ballard DJ. The Oimsted County benchmark project: primary study findings and potential implications for corporate America. Mayo Clin Proc. 1992;67:5–14
    • MEDLINE
16. Gabriel SE, Campion ME, O'Fallon WM, Melton LJ. The health care costs of nonsteroidal anti-inflammatory drug-related gastric ulcer in Olmsted County, MN, 1987–1990. Post Marketing Surveillance. 1992;6:135–146
17. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54–63
    • MEDLINE
    • CrossRef
18. Talley NJ, Phillips SF, Melton LJ, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989;111:671–674
    • MEDLINE
19. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol Med Sci. 1992;47:M116–M121
20. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of irritable bowel. BMJ. 1978;2:653–654
    • CrossRef
21. Talley NJ, Phillips SF, Melton LJ, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 1990;31:77–81
    • MEDLINE
    • CrossRef
22. Talley NJ. Diagnosing an irritable bowel: does sex matter?. Gastroenterology. 1991;100:834–837
    • MEDLINE
23. U.S. Bureau of the Census . Statistical abstract of the United States: 1992. 112th ed.. Hyattsville, MD: Public Health Service; 1993;
24. National Center for Health Statistics . Health, United States, 1991. In: 3rd ed.. DHHS Pub No. (PHS) 92-1232. Hyattsville, MD: Public Health Service; 1992;
25. Brown DM, Everhart JE. Total cost of digestive diseases in the United States, 1985. In:  Everhart JE editors. Digestive diseases in the United States: epidemiology and impact. Washington, DC: U.S. Government Printing Office; 1993;
26. Sonnenberg A, Everhart JE. Socio-economic determinants of digestive diseases. Gastroenterol Int. 1993;6:100–114
27. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54–63
    • MEDLINE
    • CrossRef
28. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102–109
    • MEDLINE
29. Lundberg GD. Cost, charges, conscience, and control (lost). JAMA. 1984;250:2509
    • MEDLINE
30. Newhouse JP, Cretin S, Witsberger CJ. Predicting hospital accounting costs. Health Care Financing Rev. 1989;11:25–33
31. Price KF. Pricing Medicare's diagnosis-related groups: charges versus estimated costs. Health Care Financing Rev. 1989;11:79–90
32. Evans RW. The socioeconomics of organ transplantation. Transplant Proc. 1985;17(Suppl 4):129–136
    • MEDLINE
33. Evans RW. Cost effectiveness analysis of transplantation. Surg Clin North Am. 1986;66:603–616
    • MEDLINE
34. Evans RW. Organ transplantation costs, insurance coverage, and reimbursement. In:  Terasaki PI editors. Clinical transplants. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1990;p. 343–355
35. Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation: costs, insurance coverage, and reimbursement. Gastroenterol Clin North Am. 1993;22:451–473
    • MEDLINE
36. Love JR, Pashos CL, Anderson GF, et al.  Costing medical care: using Medicare administrative data. Medical Care. 1994;32:JS1–JS12
    • MEDLINE
37. Iezzoni LI. Risk adjustment for measuring health care outcomes. Ann Arbor, MI: Health Administration Press; 1994;
38. U.S. General Accounting Office . Medicare: changes to HMO rate setting method are needed to reduce program costs. In: 3rd ed.. Report GAO/HEHS 94-119. Washington, DC: U.S. General Accounting Office; September 1994;